David Siderovski
American pharmacologist
From Wikipedia, the free encyclopedia
David Siderovski is a North American pharmacologist.[1] From March 2020 to November 2025, Siderovski was Chair of the HSC Department of Pharmacology & Neuroscience at the University of North Texas Health Science Center.[2] From 2012 to 2019, he was the E.J. Van Liere Medicine Professor and Chair of Physiology, Pharmacology & Neuroscience for the West Virginia University School of Medicine.[3]
- Queen's University (BSc)
- University of Toronto (PhD)
University of North Carolina at Chapel Hill
West Virginia University
University of North Texas Health Science Center
David Siderovski | |
|---|---|
 | |
| Education |
|
| Awards | ASPET's John J. Abel Award in 2004 |
| Scientific career | |
| Fields | Biochemistry Pharmacology Neuroscience Medical education |
| Institutions | Amgen Research Institute University of North Carolina at Chapel Hill West Virginia University University of North Texas Health Science Center |
| Thesis | Human Immunodeficiency Virus Type-1 Trans-activator of Transcription (HIV-1 Tat) (1997) |
| Tak Wah Mak | |
Other academic advisors | Alfred G. Gilman Robert J. Lefkowitz |
Education
Siderovski attended Earl Haig Secondary School in North York, Ontario,[4] graduating in 1985.[5] In 1989, Siderovski graduated with a BSc from Queen's University in Kingston, Ontario.[6]
Siderovski began his PhD training at the University of Toronto in May 1989. During his fifth year of his PhD, he began full-time work as a research scientist in the Quantitative Biology Laboratory of the Amgen Research Institute, Toronto.[7] He successfully defended his PhD thesis in November 1997.[8] He left the Amgen Research Institute in December 1998, having contributed to three patents as a co-inventor.[9][10][11]
Career
After completing his industrial postdoctoral position at the Amgen Research Institute in 1998,[7] Siderovski joined the faculty at the University of North Carolina at Chapel Hill as an assistant professor of pharmacology.[12] His earliest publications discuss the RGS protein superfamily,[13][14][15][16] and determinations of their varied protein structures[17][18][19] and cellular functions.[20][better source needed]
In 2004, Siderovski was named the top American Pharmacologist under 40 and awarded the John J. Abel Award by the American Society for Pharmacology and Experimental Therapeutics.[21][22][better source needed]
From 2006 to 2012, Siderovski was the Thomas J. Dark Basic Science Director of UNC's Medical Scientist Training Program.[23] In August 2014, Siderovski was appointed Director of the West Virginia University School of Medicine MD/PhD Scholars Program.[24] Siderovski has been serving as Editorial Board Member for the Journal of Biological Chemistry since 2012.[25]